VS

Versus Systems is a $6.5M nano-cap whose own 10-K opens with an explicit going-concern warning: it has 'incurred recurring losses and negative operating cash flows since inception' and states there is 'no assurance we will be able to continue as a going concern absent additional financing.' The math confirms the warning is real — FY2025 operating cash flow was -$2.05M against just $527K of cash on hand (down 82.8% YoY). That is well under three months of runway, so the company is essentially forced to raise capital, and management flags that equity issuance could leave existing holders 'significantly diluted' with new securities holding senior rights. For a 4.90M-share micro-float, that dilution risk is the dominant driver of the stock, not the operating business.

The headline 'revenue +3,711%' is a mirage created by a collapsed base: sales ran $1.11M → $271K → $57.3K → $2.18M across FY2022–FY2025. Growth off $57K is not durability; it is volatility. Worse, revenue quality is poor — the MD&A discloses just four active customers, and the largest FY2025 customer, ASPIS, is 'a significant shareholder,' making the top line partly related-party. R&D was simultaneously cut 80.5% to $48K, so the company is not funding the product pipeline that would diversify that customer base. The 99.2% gross margin is meaningless at this scale when operating margin is -99.0% and SG&A/overhead swamp everything.